RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC, demonstrating that metformin was well tolerated but associated w/no improvement in any efficacy measures https://t.co/kWSwCJ989t
Metformin Plus Concurrent Chemoradiation for Locally Advanced Non–Small Cell Lung Cancer https://t.co/bZC30xRCQD @JAMAOnc part of @JAMANetworkより
Effects of #Metformin are believed to be beyond diabetes: cancer prevention, microbiome modulation... Metformin as adjunct to chemoradiotherapy in lung cancer (NSCLS) ➡️NO or worse efficacy/toxicity ⛔️ 1.https://t.co/AlzB8Jw9F3 2.https://t.co/lzwf9Qb1Fp
RT @barlesi: Drug repurposing is not so easy; Metformin as a TME modulator failed in this trial w CCRT for Locally Advanced NSCLC; One-yea…
RT @barlesi: Drug repurposing is not so easy; Metformin as a TME modulator failed in this trial w CCRT for Locally Advanced NSCLC; One-yea…
RT @barlesi: Drug repurposing is not so easy; Metformin as a TME modulator failed in this trial w CCRT for Locally Advanced NSCLC; One-yea…
Drug repurposing is not so easy; Metformin as a TME modulator failed in this trial w CCRT for Locally Advanced NSCLC; One-year PFS rates 60.4% in the control group and 51.3% in the metformin group https://t.co/51GRDZ0oe5 via @JAMAOnc part of @JAMANetwork
RT @haigan_geka: 当科は呼吸器内科と合同で毎週抄読会を行っています。毎回2本、年間100本近い論文を読んで、議論を交わしています。先週読んだのは以下の論文です。 https://t.co/4IZWbJaPiG https://t.co/Lu7t5DUsl2
RT @haigan_geka: 当科は呼吸器内科と合同で毎週抄読会を行っています。毎回2本、年間100本近い論文を読んで、議論を交わしています。先週読んだのは以下の論文です。 https://t.co/4IZWbJaPiG https://t.co/Lu7t5DUsl2
当科は呼吸器内科と合同で毎週抄読会を行っています。毎回2本、年間100本近い論文を読んで、議論を交わしています。先週読んだのは以下の論文です。 https://t.co/4IZWbJaPiG https://t.co/Lu7t5DUsl2
RT @NRGonc: Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001…
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial https://t.co/rg5YWUC53z
RT @NatRevClinOncol: Two randomized phase II studies indicate that the addition of metformin to CRT for pts with locally advanced NSCLC doe…
RT @Latinamd: Ph II @NRGonc -LU001 Trial of #Metformin Plus Concurrent Chemoradiation For Locally Advanced NSCLC ❇️No improvement in 1 yr…
RT @Latinamd: Ph II @NRGonc -LU001 Trial of #Metformin Plus Concurrent Chemoradiation For Locally Advanced NSCLC ❇️No improvement in 1 yr…
RT @Latinamd: Ph II @NRGonc -LU001 Trial of #Metformin Plus Concurrent Chemoradiation For Locally Advanced NSCLC ❇️No improvement in 1 yr…
RT @Latinamd: Ph II @NRGonc -LU001 Trial of #Metformin Plus Concurrent Chemoradiation For Locally Advanced NSCLC ❇️No improvement in 1 yr…
Ph II @NRGonc -LU001 Trial of #Metformin Plus Concurrent Chemoradiation For Locally Advanced NSCLC ❇️No improvement in 1 yr PFS, regional recurrence or Mets w addition of Metformin #lcsm @OncoAlert @HSkinnerMDPhD https://t.co/L9ajNEm8Iy via @JAMAOn
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @NatRevClinOncol: Two randomized phase II studies indicate that the addition of metformin to CRT for pts with locally advanced NSCLC doe…
Two randomized phase II studies indicate that the addition of metformin to CRT for pts with locally advanced NSCLC doesn’t improve disease control, and might even compromise it in some pts (perhaps owing to added toxicity): https://t.co/13BApP9kZR & ht
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
RT @HSkinnerMDPhD: https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in lo…
https://t.co/gVixqnoU3l Out now in @JAMAOnc, @NRGonc LU001 was a randomized trial of chemoradiation plus metformin in locally advanced NSCLC. We obtained higher than expected 1-year PFS, however metformin had no benefit in these patients. @UPMCHillmanCC @U
RT @MLPOncoData: Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer: The NRG-L…
RT @MLPOncoData: Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer: The NRG-L…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @OncoAlert: Phase2️⃣ NRG-LU001 Addition of metformin+ChemoRad in nondiabetic, unresectable stage3⃣ #NSCLC #lungcancer ✅No improvement…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @CharuAggarwalMD: These infographics form @JAMAOnc are incredibly useful as a snapshot of newly published data/studies #LCSM
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @OncoAlert: Phase2️⃣ NRG-LU001 Addition of metformin+ChemoRad in nondiabetic, unresectable stage3⃣ #NSCLC #lungcancer ✅No improvement…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
RT @CharuAggarwalMD: These infographics form @JAMAOnc are incredibly useful as a snapshot of newly published data/studies #LCSM
Phase2️⃣ NRG-LU001 Addition of metformin+ChemoRad in nondiabetic, unresectable stage3⃣ #NSCLC #lungcancer ✅No improvement in OS or PFS
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @weoncologists: Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or…
RT @JackWestMD: These two trials, published in tandem, provide what I'd consider to be pretty definitive evidence that there isn't a man ef…
RT @JackWestMD: These two trials, published in tandem, provide what I'd consider to be pretty definitive evidence that there isn't a man ef…
RT @ADesaiMD: Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort…
These two trials, published in tandem, provide what I'd consider to be pretty definitive evidence that there isn't a man efficacy benefit, & overall more of a chance of harm, by adding metformin to treatment for NSCLC. Glad it has been asked & answ
Just out📣at @JAMAOnc Phase2️⃣ NRG-LU001 finds The addition of metformin💊to chemoradiation☢️did not improve overall or progression-free survival in nondiabetic, unresectable stage III non–small cell #lungcancer #NSCLC #LCSM https://t.co/FGB5AEqrV3 http
Two ➖#RCTs for #metformin use in #LA-#NSCLC ➕ #CRT ➡️need for identifying patients who may benefit. 💡 #BenchtoBedside effort 👏 💡 👏👏 for protocol amendments for #durvalumab based on #PACIFIC https://t.co/BaRydO1lNq https://t.co/M1PNjdarpd @JAMAOnc @OncoAl
Add this new phase III paper to the prior study that closed early, and had toxicity concerns with metformin in #lungcancer - https://t.co/AMDFwzqfUw
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
RT @MLPOncoData: Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer: The NRG-L…
New article: Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial https://t.co/LAv2nwCnZY #lungcancer #oncology https://t.co/ug4qlbOYVG
My first physics co-chair experience. Sadly, metformin didn’t pan out. There was a diff. in PFS/OS though against 0617. 🤔!? Random? 🤷♂️ So many variables to consider, makes for an interesting discussion section. What hypotheses will this be generate? http
RT @gerryhanna: So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin wi…
So much hope that #Metformin might reverse the malignant phenotype and improve cancer outcomes. This trial of Metformin with #chemotherapy and #radiotherapy in stage III #NSCLC showed no benefit to adding Metformin. #radonc @DrewMoghanaki @_ShankarSiva
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial | Lung Cancer https://t.co/fpF17uL7jx
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
RT @JAMAOnc: NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC…
NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC, demonstrating that metformin was well tolerated but associated w no improvement in any efficacy measures https://t.co/FISF7PgUUI
NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC, demonstrating that metformin was well tolerated but associated w no improvement in any efficacy measures https://t.co/xNjOxWwhAJ
NRG-LU001 randomized phase 2 trial tested addition of metformin to concurrent chemoradiation in 170 patients w stage III NSCLC, demonstrating that metformin was well tolerated but associated w no improvement in any efficacy measures https://t.co/iYtKspFWfq